Upcoming BIIB earnings date and every past earnings report, with free AI analysis of each 10-K and 10-Q straight from SEC EDGAR filings.
October 28, 2026
Biogen was scheduled to report on this date in the final Finnhub and Financial Modeling Prep calendar snapshot. Later schedule changes are not reflected.
Biogen reported 2026-Q2 total revenue of $2,736.0 million (+3.4% YoY), driven by the addition of Apellis products and growth in rare disease therapies, though…
Biogen delivered a solid Q1 2026 with revenue up 1.9% YoY to $2.48B, while net income surged 32.8% to $319.5M and operating cash flow nearly tripled to…
Biogen (BIIB) posted modest 2.2% revenue growth to $9.89B in FY2025, but net income fell 20.8% to $1.29B, pressured by higher costs and increased long-term…
Biogen (BIIB) is scheduled to report earnings on October 28, 2026, according to Finnhub's earnings calendar. Dates can change until the company officially confirms them.
Biogen's most recent earnings report was its Q2 2026 10-Q, filed with the SEC on July 29, 2026.
EarningsLens publishes free AI analysis of every BIIB 10-K and 10-Q filing. The latest covers Q2 2026 — open it from the report history on this page.
Like all U.S.-listed public companies, Biogen reports four times a year: three quarterly 10-Q filings and one annual 10-K filing with the SEC.